Susan Schenk

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Susan Schenk
ResidenceNew Zealand
CitizenshipCanada/New Zealand
Alma materConcordia University
AwardsFellow of The Royal Society of New Zealand
Scientific career
Fieldsphysical and chemical aspects of drug abuse
InstitutionsTexas A&M University Victoria University of Wellington
Doctoral advisorPeter Shizgal

Susan Schenk, sometimes Lovell-Schenk, (born 1954) is a New Zealand psychology academic. She is currently a full professor at the Victoria University of Wellington.[1]

Academic career[edit]

After a 1982 PhD titled 'The substrate for prefrontal cortical self-stimulation: a psychophysical investigation' at Concordia University, she completed an NSERC funded post/doctoral position with Peter Milner at McGill University. She then moved to Texas A&M University where she moved through the ranks from Assistant Professor to Professor. In 2001 she moved to the Victoria University of Wellington, as a full professor.[1]

Most of her research relates to the physical and chemical aspects of drug abuse.[2][3][4]

Selected works[edit]

  • Horger, Brian A., Keith Shelton, and Susan Schenk. "Preexposure sensitizes rats to the rewarding effects of cocaine." Pharmacology Biochemistry and Behavior 37, no. 4 (1990): 707-711.
  • Horger, Brian A., Melissa K. Giles, and Susan Schenk. "Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine." Psychopharmacology 107, no. 2-3 (1992): 271-276.
  • Schenk, Susan, Gary Lacelle, Kathleen Gorman, and Zalman Amit. "Cocaine self-administration in rats influenced by environmental conditions: implications for the etiology of drug abuse." Neuroscience Letters 81, no. 1-2 (1987): 227-231.
  • Schenk, Susan, Brian A. Horger, Rachel Peltier, and Keith Shelton. "Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats." Brain Research 543, no. 2 (1991): 227-235.
  • Schenk, Susan, Brian Partridge, and Toni S. Shippenberg. "U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking." Psychopharmacology 144, no. 4 (1999): 339-346.


  1. ^ a b "Susan Schenk - School of Psychology - Victoria University of Wellington".
  2. ^ "Susan Schenk: ecstasy and agony". 17 March 2011.
  3. ^ "Mexican tripping weed may help to wean addicts". Stuff.
  4. ^ "Ecstasy is a dangerous drug and should remain illegal". Stuff.

External links[edit]